IP Library Granted Patent US 10,570,168
Granted Patent B2
US 10,570,168 · App. 15/518,527 · Granted Feb 25, 2020

2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compounds

Inventors: Hugh Griffith (Edinburgh, GB); Christopher McGuigan (Cardiff, GB); Valentina Ferrari (Cardiff, GB); Michaela Serpi (Cardiff, GB); Carmen Jimenez Antunez (Cardiff, GB)
Assignee: Nucana plc
C07H19/20C07H19/173
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,570,168
App. No.
15/518,527
Granted
Feb 25, 2020
Kind
B2
Abstract

Disclosed are chemical compounds, the compounds for use in a method of treatment, particularly in a method of prophylaxis or treatment for cancer, a process for preparation of the compounds and pharmaceutical compositions comprising the compounds. The compounds may, in particular, be useful in the treatment of leukaemia, lymphoma and/or solid tumours in homo sapiens . The compounds are derivatives of cordycepin (3′-deoxyadenosine) having a 2′ and/or 5′-amino-acid ester phosphoramidate moiety.

Claims (5)

1. 3′-Deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)] phosphate:

or a pharmaceutically acceptable salt, ester, salt of an ester, or solvate thereof.

2. The compound of claim 1 , wherein the compound is 3′-Deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)] phosphate:

3. A pharmaceutical composition, comprising the compound according to claim 1 ; and a pharmaceutically acceptable excipient.

4. The pharmaceutical composition of claim 3 , wherein the compound is 3′-Deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)] phosphate:

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2019
From: GRIFFITH, HUGH; MCGUIGAN, CHRISTOPHER
To: NUCANA BIOMED LIMITED
Reel/Frame 048367/0220 →
CHANGE OF NAME Recorded Mar 21, 2018
From: NUCANA BIOMED LIMITED
To: NUCANA PLC
Reel/Frame 045303/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2017
From: GRIFFITH, HUGH; FERRARI, VALENTINA; SERPI, MICHAELA; ANTUNEZ, CARMEN JIMENEZ
To: NUCANA BIOMED LIMITED
Reel/Frame 043433/0208 →
Priority Claims (2)
GB 1421211.2 · Nov 28, 2014 · national
GB 1519316.2 · Nov 2, 2015 · national
Continuity (1)
Related Publication 20170253629A1 · Sep 7, 2017